Taiwan · Delayed Price · Currency is TWD Merdury Biopharmaceutical Statistics
Total Valuation
TPEX:6932 has a market cap or net worth of TWD 2.29 billion. The enterprise value is 2.19 billion.
| Market Cap | 2.29B |
| Enterprise Value | 2.19B |
Important Dates
The next estimated earnings date is Thursday, August 20, 2026.
| Earnings Date | Aug 20, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:6932 has 422.03 million shares outstanding. The number of shares has increased by 2.85% in one year.
| Current Share Class | 422.03M |
| Shares Outstanding | 422.03M |
| Shares Change (YoY) | +2.85% |
| Shares Change (QoQ) | +0.26% |
| Owned by Insiders (%) | 47.70% |
| Owned by Institutions (%) | n/a |
| Float | 196.56M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 11.39 |
| P/TBV Ratio | 11.67 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.76, with a Debt / Equity ratio of 0.21.
| Current Ratio | 7.76 |
| Quick Ratio | 6.99 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.75 |
| Interest Coverage | -62.33 |
Financial Efficiency
Return on equity (ROE) is -22.78% and return on invested capital (ROIC) is -12.12%.
| Return on Equity (ROE) | -22.78% |
| Return on Assets (ROA) | -11.40% |
| Return on Invested Capital (ROIC) | -12.12% |
| Return on Capital Employed (ROCE) | -21.89% |
| Weighted Average Cost of Capital (WACC) | -1.83% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, TPEX:6932 has paid 38,000 in taxes.
| Income Tax | 38,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -38.94% in the last 52 weeks. The beta is -1.12, so TPEX:6932's price volatility has been lower than the market average.
| Beta (5Y) | -1.12 |
| 52-Week Price Change | -38.94% |
| 50-Day Moving Average | 5.97 |
| 200-Day Moving Average | 7.77 |
| Relative Strength Index (RSI) | 42.51 |
| Average Volume (20 Days) | 554,224 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -52.61M |
| Pretax Income | -51.58M |
| Net Income | -51.62M |
| EBITDA | -43.89M |
| EBIT | -52.61M |
| Earnings Per Share (EPS) | -0.12 |
Balance Sheet
The company has 136.49 million in cash and 42.80 million in debt, with a net cash position of 93.69 million or 0.22 per share.
| Cash & Cash Equivalents | 136.49M |
| Total Debt | 42.80M |
| Net Cash | 93.69M |
| Net Cash Per Share | 0.22 |
| Equity (Book Value) | 200.77M |
| Book Value Per Share | 0.44 |
| Working Capital | 132.39M |
Cash Flow
In the last 12 months, operating cash flow was -45.99 million and capital expenditures -10.70 million, giving a free cash flow of -56.69 million.
| Operating Cash Flow | -45.99M |
| Capital Expenditures | -10.70M |
| Depreciation & Amortization | 8.72M |
| Net Borrowing | -4.08M |
| Free Cash Flow | -56.69M |
| FCF Per Share | -0.13 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TPEX:6932 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.85% |
| Shareholder Yield | -2.85% |
| Earnings Yield | -2.26% |
| FCF Yield | -2.48% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |